ArticleBreast cancer research and treatment2025

The prognostic value of changes in Ki67 following neoadjuvant chemotherapy in residual triple-negative breast cancer: a Swedish nationwide registry-based study.

Jenny Nyqvist-Streng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.